Apertura – Grupo 2
| Pos | equipo | PTS | PJ | G | E | P | GF | GC | DG | TA | TR | %GF | %GC | Racha | Últimos | Prox |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 |  EY Consulting | 18 | 6 | 6 | 0 | 0 | 22 | 12 | 10 | 1 | 0 | 3.67 | 2.00 | V6 |  | |
| 2 |  Monitor Deloitte | 16 | 8 | 5 | 1 | 2 | 23 | 21 | 2 | 4 | 0 | 2.88 | 2.63 | V1 |  | |
| 3 |  Canal de Isabel II | 15 | 6 | 5 | 0 | 1 | 20 | 6 | 14 | 1 | 2 | 3.33 | 1.00 | V5 |  | |
| 4 | EY Data | 12 | 7 | 4 | 0 | 3 | 18 | 12 | 6 | 5 | 0 | 2.57 | 1.71 | D1 |  | |
| 5 |  Valcor Consultores | 10 | 7 | 3 | 1 | 3 | 23 | 17 | 6 | 4 | 0 | 3.29 | 2.43 | V1 |  | |
| 6 |  Accenture World | 10 | 7 | 3 | 1 | 3 | 14 | 16 | -2 | 3 | 1 | 2.00 | 2.29 | V2 |  | |
| 7 | McKinsey A | 4 | 7 | 1 | 1 | 5 | 11 | 17 | -6 | 1 | 0 | 1.57 | 2.43 | D3 | | |
| 8 |  Abante Asesores | 3 | 7 | 1 | 0 | 6 | 5 | 19 | -14 | 1 | 0 | 0.71 | 2.71 | D2 |  | |
| 9 |  Insud Pharma | 3 | 7 | 1 | 0 | 6 | 13 | 29 | -16 | 3 | 0 | 1.86 | 4.14 | D3 |  |
